CureMeAbroad raises $1.1M pre-seed led by SteerX Ventures

CureMeAbroad has raised $1.1 million in a pre-seed round led by SteerX Ventures, with existing investor AIRA doubling down. The Bengaluru-based startup, founded in 2025 by Aditya Oza and Mikhail Bohra, is building an end-to-end platform for patients seeking healthcare across borders.

Oza previously scaled EV brand EMotorad to over $100 million in revenue, while Bohra bootstrapped Harbor365 to $10 million. The funding will support CureMeAbroad’s expansion in a market where cross-border medical travel is growing but still lacks integrated digital solutions.

The round stands out for its size in the healthtech pre-seed space, particularly in India, where recent funding activity has leaned toward AI-driven diagnostics and biotech. CureMeAbroad’s focus on patient coordination and logistics—rather than clinical innovation—positions it differently from peers like Mandrake Bio or CurvetAI, which raised pre-seed rounds in the same period.

Investor interest in medical tourism platforms has been sporadic, but the participation of SteerX Ventures, a firm with a track record in mobility and consumer tech, suggests a bet on the founders’ operational experience. How CureMeAbroad differentiates itself from traditional medical travel agencies will be key to watch.

Sources: pharmabiz.com · expresshealthcare.in